Citation 176593

SCHURIG,JE: ROSE,WC: HIRTH,RS: SCHLEIN,A: HUFTALEN,JB: FLORCZYK,AP: BRADNER,WT:. (1984). TALLYSOMYCIN S-10-B: EXPERIMENTAL ANTITUMOR ACTIVITY AND TOXICITY.. 13(3)

Citation Details

Title	TALLYSOMYCIN S-10-B: EXPERIMENTAL ANTITUMOR ACTIVITY AND TOXICITY.
Authors	SCHURIG,JE: ROSE,WC: HIRTH,RS: SCHLEIN,A: HUFTALEN,JB: FLORCZYK,AP: BRADNER,WT:
Year	1984
Volume	13
Issue	3

Summary

Year: 1984

Journal: Unknown

Organisms and Their Experiments (2)

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	TALLYSOMYCIN S-10-B	ACTIVE
2	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	TALLYSOMYCIN S-10-B	ACTIVE
3	LEUKOPENIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVO	TALLYSOMYCIN S-10-B	WEAK ACTIVITY
4	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	TALLYSOMYCIN S-10-B	INACTIVE
5	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	TALLYSOMYCIN S-10-B	INACTIVE
6	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	TALLYSOMYCIN S-10-B	INACTIVE
7	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	TALLYSOMYCIN S-10-B	ACTIVE
8	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	TALLYSOMYCIN S-10-B	ACTIVE
9	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	TALLYSOMYCIN S-10-B	ACTIVE
10	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	TALLYSOMYCIN S-10-B	INACTIVE
11	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	TALLYSOMYCIN S-10-B	ACTIVE
12	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	TALLYSOMYCIN S-10-B	ACTIVE
13	RESPIRATORY SYSTEM TOXICITY	PHARMACOLOGY OF COMPOUND - IN VIVO	TALLYSOMYCIN S-10-B	ACTIVE
14	RESPIRATORY SYSTEM TOXICITY	PHARMACOLOGY OF COMPOUND - IN VIVO	TALLYSOMYCIN S-10-B	ACTIVE

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	BLEOMYCIN	ACTIVE
2	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	BLEOMYCIN	ACTIVE
3	LEUKOPENIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVO	BLEOMYCIN	WEAK ACTIVITY
4	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	BLEOMYCIN	INACTIVE
5	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	BLEOMYCIN	INACTIVE
6	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	BLEOMYCIN	INACTIVE
7	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	BLEOMYCIN	ACTIVE
8	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	BLEOMYCIN	ACTIVE
9	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	BLEOMYCIN	ACTIVE
10	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	BLEOMYCIN	INACTIVE
11	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	BLEOMYCIN	ACTIVE
12	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	BLEOMYCIN	ACTIVE
13	RESPIRATORY SYSTEM TOXICITY	PHARMACOLOGY OF COMPOUND - IN VIVO	BLEOMYCIN	ACTIVE
14	RESPIRATORY SYSTEM TOXICITY	PHARMACOLOGY OF COMPOUND - IN VIVO	BLEOMYCIN	ACTIVE

Show SPARQL Queries (1)